Expression Table for this CRE
| CNhs13845 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2 | 2.2 |
| CNhs12732 | Renal Epithelial Cells, donor3 | 1.4 |
| CNhs13919 | CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3 | 0.9 |
| CNhs13441 | eye - muscle superior, donor2 | 0.8 |
| CNhs12097 | Trabecular Meshwork Cells, donor2 | 0.8 |
| CNhs12480 | MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2 | 0.8 |
| SRX9760367 | skeletal muscle_1_h_after_exercise (Individual 4) | 0.8 |
| CNhs14595 | Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1 | 0.8 |
| CNhs11873 | mucinous cystadenocarcinoma cell line:MCAS | 0.7 |
| CNhs13920 | CD4+CD25-CD45RA- memory conventional T cells expanded, donor2 | 0.7 |
| CNhs13049 | acute myeloid leukemia (FAB M7) cell line:M-MOK | 0.7 |
| CNhi10939_ACC | Human primary dermal lymphatic vascular endothelial cells, biol_rep1 | 0.6 |
| CNhs12094 | Corneal Epithelial Cells, donor2 | 0.6 |
| CNhs11891 | hereditary spherocytic anemia cell line:WIL2-NS | 0.6 |
| CNhs12404 | Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction) | 0.6 |
| CNhs11779 | diaphragm, fetal, donor1 | 0.6 |
| CNhs12530 | neutrophil PMN, donor3 | 0.6 |
| CNhs14499 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3 | 0.6 |
| CNhs14600 | Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2 | 0.6 |
| CNhs12120 | Renal Proximal Tubular Epithelial Cell, donor3 | 0.6 |
| CNhs12371 | mesenchymal precursor cell - cardiac, donor4 | 0.6 |
| CNhs11876 | testicular germ cell embryonal carcinoma cell line:ITO-II | 0.5 |
| CNhs12195 | Dendritic Cells - monocyte immature derived, donor2 | 0.5 |
| CNhs12812 | salivary acinar cells, donor3 | 0.5 |
| CNhs12802 | K562 erythroblastic leukemia response to hemin, day02, biol_rep3 | 0.5 |
| CNhs11763 | uterus, fetal, donor1 | 0.5 |
| CNhs11842 | fibrous histiocytoma cell line:GCT TIB-223 | 0.5 |
| CNhs13060 | acute myeloid leukemia (FAB M6) cell line:F-36E | 0.5 |
| CNhs12375 | mesenchymal precursor cell - ovarian cancer right ovary, donor2 | 0.5 |
| CNhs12572 | Lens Epithelial Cells, donor3 | 0.4 |
| CNhs14599 | Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2 | 0.4 |
| CNhs12895 | H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3) | 0.4 |
| CNhs12089 | Renal Mesangial Cells, donor2 | 0.4 |
| CNhs13165 | Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9) | 0.4 |
| CNhs13476 | CD14+ monocytes - treated with IFN + N-hexane, donor2 | 0.4 |
| CNhs12799 | K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3 | 0.4 |
| CNhs12463 | K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1 | 0.4 |
| CNhs11749 | squamous cell carcinoma cell line:JHUS-nk1 | 0.4 |
| CNhs14587 | Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1 | 0.4 |
| CNhs11830 | peripheral neuroectodermal tumor cell line:KU-SN | 0.4 |
| CNhs13466 | CD14+ monocytes - treated with IFN + N-hexane, donor1 | 0.4 |
| CNhs13969 | H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1 | 0.4 |
| CNhs12930 | Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1) | 0.4 |
| CNhs14552 | medial temporal gyrus, adult, donor10258 | 0.4 |
| SRX4001466 | CAGE profiling after treatment with JQ1 BET inhibitor in lung cancer cell line: H23_DMSO_12h_R1 | 0.4 |
| CNhs11882 | adenocarcinoma cell line:IM95m | 0.4 |
| SRX4504714 | human CAGE MCF-7, response to HRG, 15 min, biol_rep2 | 0.4 |
| CNhs13160 | Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4) | 0.4 |
| CNhs13541 | CD14+CD16+ Monocytes, donor1 | 0.3 |
| CNhs11825 | large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF | 0.3 |